U.S. nuclear power workers show no unexepected radiation related cancer

NewsGuard 100/100 Score

A first-of-its-kind study of more than 53,000 U.S. nuclear power workers has found that employees in the commercial nuclear industry are less likely than the general population to die from cancer or non-cancer diseases due, in large measure, to the so-called "healthy worker effect."

The study by Columbia University's Mailman School of Public Health tracked workers from 15 nuclear utilities in the U.S. for periods of up to 18 years between 1979 and 1997. Mortality rates of these workers showed that they were 60 percent lower than cause-specific U.S. mortality rates for a population similar in terms of gender, age and calendar year. In order to work in the nuclear industry, workers have to be healthy and are usually required to have annual medical check-ups.

The most important results of this study were findings with respect to radiation-related leukemia and radiation-related other cancers. According to the records, which were maintained by the facilities themselves and by the Nuclear Regulatory Commission and the Department of Energy, positive, although non-statistically-significant, associations with radiation were seen for mortality from some forms of leukemia and other cancers as a whole. The magnitude of these associations is very similar to those from other radiation studies on which current radiation safety standards are based, indicating that the standards are appropriate.

The researchers did report, however, a strong positive and statistically significant association between radiation dose and death from arteriosclerotic heart disease, including coronary heart disease.

Cautions Geoffrey Howe, PhD, professor of Epidemiology at the Mailman School and principal investigator of the study, "While associations with heart disease have been reported by some other occupational studies, the magnitude of the present association is not consistent with them, and, therefore, needs cautious interpretation and merits further attention."

According to Dr. Howe, "With a mean age of 45 years, this cohort is still relatively young which explains the small number of deaths. Further follow-up and data from an on-going analysis of nuclear workers from 15 countries will provide an additional opportunity for studying the effects of low-dose radiation exposures and greater power to evaluate the present findings."

This study represents the culmination of efforts by individuals in industry, government and academia to combine available sources of information on occupational radiation doses received by U.S. commercial nuclear workers. Currently, there is no single depository of radiation doses in the U.S. and researchers believe one is desirable.

The study, "Analysis of the Mortality Experience Amongst U.S. Nuclear Power Industry Workers After Chronic Low-Dose Exposure to Ionizing Radiation," is published in the November issue of Radiation Research (Rad Res 162, 517-526, 2004), the official journal of the American Radiation Research Society. The 15 nuclear utilities voluntarily participated in the study conducted by the independent researchers. The results are of value in informing U.S. nuclear workers about the latest findings on the safety of their workplace.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study unveils novel bladder cancer diagnostic model based on key mitochondrial genes